IDH1 mutation of gliomas with long-term survival analysis

By Myung Jae Kyung   Cho Hwa Jin   Park Chul-Kee   Kim Seung-Ki   Phi Ji Hoon   Park Sung-Hye  

Oncology Reports, Vol. 28, Iss. 5, 2012-11 ,pp. : 1639-1644

Spandidos Publications

Access to resources Recommend Favorite

Correlation of IDH1/2 mutation with clinicopathologic factors and prognosis in anaplastic gliomas: a report of 203 patients from China

By Zhang Chuan-Bao   Bao Zhao-Shi   Wang Hong-Jun   Yan Wei   Liu Yan-Wei   Li Ming-Yang   Zhang Wei   Chen Ling   Jiang Tao  

Journal of Cancer Research and Clinical Oncology, Vol. 140, Iss. 1, 2014-01 ,pp. : 45-51

Springer Publishing Company

Access to resources Recommend Favorite

Response to postoperative radiotherapy as a prognostic factor for patients with low-grade gliomas

By          

Oncology Letters, Vol. 4, Iss. 3, 2012-01 ,pp. : 455-460

Spandidos Publications

Access to resources Recommend Favorite

Prognostic significance of histological grading, p53 status, YKL-40 expression, and IDH1 mutations in pediatric high-grade gliomas

By Antonelli Manila   Buttarelli Francesca   Arcella Antonietta   Nobusawa Sumihito   Donofrio Vittoria   Oghaki Hiroko   Giangaspero Felice  

Journal of Neuro-Oncology, Vol. 99, Iss. 2, 2010-09 ,pp. : 209-215

Springer Publishing Company

Access to resources Recommend Favorite

Newly proposed therapy-related myelodysplastic syndrome prognostic score predicts significant differences in overall survival and leukemia-free survival in patients treated with azacitidine

By Breccia Massimo  

Leukemia and Lymphoma, Vol. 54, Iss. 8, 2013-08 ,pp. : 1786-1787

Informa Healthcare

Access to resources Recommend Favorite